Frontida Biopharm Revenue and Competitors
Estimated Revenue & Valuation
- Frontida Biopharm's estimated annual revenue is currently $7.2M per year.
- Frontida Biopharm's estimated revenue per employee is $100,500
- Frontida Biopharm's total funding is $8.4M.
Employee Data
- Frontida Biopharm has 72 Employees.
- Frontida Biopharm grew their employee count by -5% last year.
Frontida Biopharm's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Aurora Operations and Process Technologies | Reveal Email/Phone |
2 | VP, Quality | Reveal Email/Phone |
3 | Associate Director, Engineering | Reveal Email/Phone |
4 | Director, Research & Development Technical Sevices and Validation | Reveal Email/Phone |
5 | Associate Director Process Engineering | Reveal Email/Phone |
6 | Director Quality Assurance | Reveal Email/Phone |
7 | Associate Director, ARD | Reveal Email/Phone |
8 | Director, Human Resources | Reveal Email/Phone |
9 | Procurement Manager | Reveal Email/Phone |
10 | Compliance Training Manager | Reveal Email/Phone |
Frontida Biopharm Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $43.2M | 215 | 6% | N/A | N/A |
#2 | $81.8M | 407 | 10% | N/A | N/A |
#3 | $11.7M | 58 | 0% | N/A | N/A |
#4 | $1011.8M | 5034 | -9% | N/A | N/A |
#5 | $44.8M | 223 | 1% | N/A | N/A |
#6 | $13.1M | 65 | 5% | N/A | N/A |
#7 | $16.5M | 82 | 41% | N/A | N/A |
#8 | $17.3M | 86 | -5% | N/A | N/A |
#9 | $67.9M | 338 | 23% | N/A | N/A |
#10 | $14.9M | 74 | 7% | N/A | N/A |
What Is Frontida Biopharm?
Frontida Biopharm, Inc., an affiliate of Frontage Laboratories, Inc., is a Contract Development and Manufacturing Organization supporting biopharmaceutical companies in the scale-up and commercial manufacture of immediate and controlled release oral solid dose products. Frontida offers the capability to manufacture Highly Potent Active Ingredient (HPAI) products, Combination Products, as well as DEA schedules II – V products. Its patented Duragran® granulation process eliminates the need for traditional extrusion and compaction manufacturing steps, enhances drug loading, and creates better engineered and lower production-cost controlled release products.
keywords:N/A
$8.4M
Total Funding
72
Number of Employees
$7.2M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Frontida Biopharm News
Global Pharmaceutical Contract Manufacturing Market is projected to reach a market value of US$329.7 Billion EIN News
Other Companies in Philadelphia
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $16.2M | 72 | -15% | N/A |
#2 | $17.5M | 72 | 3% | N/A |
#3 | $15M | 72 | 11% | N/A |
#4 | $14.7M | 72 | 4% | N/A |
#5 | $18.8M | 72 | 18% | N/A |